# Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America

> **NCT00312663** · PHASE1,PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 24 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **BIOLOGICAL:** Falciparum Malaria Protein 11 with AS01B adjuvant.

## Key facts

- **NCT ID:** NCT00312663
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-10
- **Final completion:** 2007-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-11-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312663, "Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00312663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*